903 TOFACITINIB DEMONSTRATES PRELIMINARY EFFICACY IN INDUCTION OF REMISSION IN CHRONIC POUCHITIS
Emi Khoo(The University of Queensland), Jakob Begun, Anna Amiss(Mater Research), Anthony Croft(QIMR Berghofer Medical Research Institute), Kate D. Lynch(University of Oxford), Rupert W. Leong(The University of Sydney), Susan J. Connor(Liverpool Hospital), Nik S. Ding(The University of Melbourne), Yoon‐Kyo An(Mater Hospital), Waled Mohsen(Gold Coast Hospital), Robert V. Bryant(Queen Elizabeth Hospital), Miles Sparrow(Alfred Health), Peter De Cruz(The University of Melbourne)
Cited by 0
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
|The Lancet|2017|198